Bill Texts: KS SB212 | 2025-2026 | Regular Session

Bill Title: Enacting the prescription drug cost and affordability review act to establish the prescription drug pricing board and prescription drug affordability stakeholder council to review the cost of prescription medications and establish upper payment limits for certain prescription drugs.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced) 2025-02-06 - Senate Referred to Committee on Financial Institutions and Insurance [SB212 Detail]

Bill Drafts

RevisionDateFormatSourceView
Introduced2025-02-05PDFLinkView

Amendments

AmendmentDateDispositionFormatSourceView
No bill amendments currently on file for Kansas SB212

Supplemental Documents

TitleDescriptionDateFormatSourceView
No supplemental documents for Kansas SB212 currently on file.

Social Comments on KS SB212

feedback